Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Revenue (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed Revenue for 2 consecutive years, with $251000.0 as the latest value for Q1 2024.

  • On a quarterly basis, Revenue changed N/A to $251000.0 in Q1 2024 year-over-year; TTM through Dec 2024 was $251000.0, a N/A change, with the full-year FY2024 number at $251000.0, down 99.24% from a year prior.
  • Revenue was $251000.0 for Q1 2024 at Artiva Biotherapeutics, down from $1.8 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $26.7 million in Q3 2023 to a low of $251000.0 in Q1 2024.